Jefferies Cuts Price Target on Bojangles' (BOJA) to $22 Following 4Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Piper Jaffray Remains Neutral Following Bojangles' (BOJA) Better-Than-Expected 4Q
March 11, 2016 7:52 AM ESTPiper Jaffray maintained a Neutral rating on Bojangles' (NASDAQ: BOJA), and cut the price target to $17.00 (from $20.00), following the company's 4Q earnings report. The company reported 4Q15 operating earnings of $0.22 vs. consensus expectations of $0.19 per share.
Analyst Nicole Regan commented, "Bojangles' reported solid 4Q15 results including... More
Bojangles' (BOJA) Estimates Raised at RBC Capital Post Q4
March 11, 2016 7:12 AM ESTRBC Capital analyst, David Palmer, raised his 2016 EPS estimate for Bojangles (NASDAQ: BOJA) following the company's 4Q EPS beat.
Systemwide SSS growth of 0.6% fell short of expectations (RBCe 1.9%; cons. 1.7%) due to severe weather in October, competitive discounting (e.g., 4 for $4, etc.), and the impact of McDonald's All-Day Breakfast, 4Q EPS (RBCe $0.22; cons. $0.20) exceeded estimates due to lower than... More
After-Hours Stock Movers 03/10: (SSKN) (ULTA) (FNSR) Higher; (FXCM) (ZUMZ) (LOCO) Lower (more...)
March 10, 2016 6:02 PM ESTSTRATA Skin Sciences, Inc. (NASDAQ: SSKN) 35.2% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) approved STRATAs PMA supplement for the MelaFind System.
FXCM Inc. (NYSE: FXCM) 18.6% LOWER; Leucadia National Corporation (NYSE: LUK) and FXCM Inc. (NYSE: FXCM) announced that they have entered into a memorandum of understanding (the MOU) to amend the terms of their Amended and Restated Credit Agreement (the Credit Agreement), and... More
Bojangles' (BOJA) Tops Q4 EPS by 3c, Comps Increase 0.6%, Offers FY Guidance
March 10, 2016 4:08 PM ESTBojangles' (NASDAQ: BOJA) reported Q4 EPS of $0.22, $0.03 better than the analyst estimate of $0.19. Revenue for the quarter came in at $128.8 million versus the consensus estimate of $127.66 million.
System-wide comparable restaurant sales increased 0.6%GUIDANCE:
Bojangles' sees FY2016 EPS of... More
Trading Radar for 3/10: Dollar General (DG), Canadian Solar (CSIQ), Plug Power (PLUG), Veifone (PAY) Report
March 9, 2016 2:56 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
BioLineRx (Nasdaq: BLRX) - consensus loss $0.06
CECO Environmental (Nasdaq: CECE) - consensus EPS $0.21
Canadian Solar (Nasdaq: CSIQ) - consensus EPS $0.76
Cantel Medical (NYSE: CMN) - consensus EPS $0.34
Cardiome Pharma (Nasdaq:... More

